课题基金 / 基金详情

Flomark: safer hospital infusions through pioneering devices and data analytics

Flomark: safer hospital infusions through pioneering devices and data analytics
Flomark:通过先进的设备和数据分析实现更安全的医院输液
批准号:
10027005
负责人:
金额:
$63.3万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
保持正确的体液平衡对病人的康复尤为重要。然而,20%接受静脉输液的患者由于不正确的静脉给药而出现医疗并发症。我们将发展三项创新,以解决流体平衡管理中的三个紧迫问题。1)医院点滴在80%的住院病人中,重力给药装置(“点滴”)被用来将液体直接输送到病人的静脉(输液)中。但85%的情况下,滴注使用不当,导致患者获得液体过快或过慢。我们已经获得了一项改进滴注的专利,Flomark消耗品。它使用直观,更可靠,节省员工时间,成本与最先进的滴管相同。我们将寻求监管部门的批准,测试和生产该产品。目前还没有能够测量此流量范围的流量计。2)输液泵在许多医院的输液中,使用静脉注射泵。目前的泵无法感知流体的流动速度,因此必须依靠昂贵而笨重的电池和执行器来输送流体。我们将Flomark消耗品与电子产品相结合,轻松感知和调节流量,创建**Flomark调节器**。这将是一个泵的成本的一小部分,更容易使用,并有更少的缺点。我们的目标是生产一个预生产原型。3)液体平衡在重症监护(ICU)中,液体平衡(患者的液体输入与液体输出的比较)非常重要。虽然重症监护资源丰富,但这是人工监测和计算的,而且有35%的时间是不准确的。与心脏和呼吸监测不同,尽管流体输入和输出的重要性得到公认,但它没有实时数据馈送。我们将修改Flomark消耗品来测量流体输出(通过导管),用相同的Flomark调节器设计来感知。这将允许为重症监护患者的液体输入和输出产生准确的实时数据-这是一个真正的变革步骤。此外,我们将构建软件来分析这些数据,以预测潜在的患者伤害(Flomark软件平台),并支持知情的临床决策和处方。这三项创新将极大地提高流体管理的效率和安全性。它们将颠覆当前的行业,以更低的成本提供改进的产品,并改善数据,从而改善护理,为全球医疗保健提供商节省大量资金。**参考资料可根据要求提供**
英文摘要
Maintaining correct fluid balance is particularly important for patient recovery. However, 20% of patients receiving intravenous (IV) fluids suffer medical complications because of incorrect IV administration.We will develop three innovations to address three pressing problems in fluid balance management.1) Hospital dripsIn 80% of all hospital admissions, a gravity administration set ("drip") is used to convey fluids directly into the patient's veins (infusion). But 85% of the time, the drip is used incorrectly, resulting in patients getting fluid too quickly or too slowly.We have patented an improved drip, the **Flomark Consumable**. It is intuitive to use, more reliable, saves staff time, and is the same cost as state-of-art drips. We will seek regulatory approval, test and manufacture this product. No flow meter capable of measuring this flow range is currently available.2) Infusion pumpsDuring many hospital infusions, an IV pump is used. Current pumps cannot sense how fast the fluid is flowing, and therefore must rely on expensive and heavy batteries and actuators to deliver fluid flow.We will combine the Flomark Consumable with electronics to easily sense and regulate flow, creating the **Flomark Regulator**. This will be a fraction of the cost of a pump, be easier to use, and have fewer drawbacks. We aim to produce a pre-production prototype.3) Fluid balanceIn intensive care (ICU), fluid balance (a patient's fluid input compared with fluid output) is very important. Although intensive care is highly resourced, this is monitored and calculated manually, and done inaccurately 35% of the time. Unlike cardiac and respiratory monitoring, there is no real-time data feed for fluid input and output, despite its acknowledged importance.We will modify the Flomark Consumable to measure fluid output (via a catheter), sensing this with the same Flomark Regulator design. This will allow accurate real time data to be produced for fluid _input and output_ for intensive care patients - a truly transformative step. Further to this, we will build software to analyse this data to predict potential patient harm (the **Flomark Software Platform**), and support informed clinical decisions and prescribing.These three innovations will vastly improve efficiency and safety in fluid management. They will disrupt the current industry, provide improved products for less cost, and improve data and thus care, saving healthcare providers worldwide a huge amount of money.**REFERENCES AVAILABLE ON REQUEST**
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金